Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience

2020140 citationsJournal Articlegold Open Access

Authors

Antonio Russo · University of Campania "Luigi Vanvitelli"

Marcello Silvestro · University of Campania "Luigi Vanvitelli"

Fabrizio Scotto di Clemente · University of Campania "Luigi Vanvitelli"

Francesca Trojsi · University of Campania "Luigi Vanvitelli"

Alvino Bisecco · University of Campania "Luigi Vanvitelli"

Simona Bonavita · University of Campania "Luigi Vanvitelli"

Alessandro Tessitore

Abstract

These real-world data support monthly erenumab 70 or 140 mg s.c. as a safe and effective preventive treatment to reduce headache frequency and severity in chronic migraine patients experiencing previous unsuccessful preventive treatments.

Topics & Keywords

Migraine and Headache Studies Trigeminal Neuralgia and Treatments Cardiovascular Syncope and Autonomic Disorders

Publication Details

Published in: The Journal of Headache and Pain

Volume 21, Issue 1, pp. 69-69

DOI: 10.1186/s10194-020-01143-0

Field-Weighted Citation Impact: 15.62

Command Palette

Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience

Authors

Abstract

Topics & Keywords

Publication Details